AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
50 hedge funds and large institutions have $184M invested in Agile Therapeutics in 2016 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
4% more funds holding
Funds holding: 48 → 50 (+2)
Holders
50
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$2.57M | |
| 2 | +$1.16M | |
| 3 | +$623K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$336K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$313K |
Top Sellers
| 1 | -$3.04M | |
| 2 | -$1.6M | |
| 3 | -$1.03M | |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$822K |
| 5 |
JGC
J. Goldman & Co
New York
|
-$413K |